Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03748862 · ClinicalTrials.gov registry record

The Effect of Primary Care Opioid Taper Plans on Sustained Opioid Taper

A clinical trial of Opiate Replacement Therapy, sponsored by Kaiser Permanente.

Completed
Registry status
2,500
Enrollment target
1
Study location

NCT03748862 is a study of Opiate Replacement Therapy that has completed, run by Kaiser Permanente. The registered enrollment target is 2,500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03748862, a study of Opiate Replacement Therapy, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
2,500 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to examine the effects of opioid taper plans as documented in the electronic medical record for Kaiser Permanente Washington (KPWA) patients. The study will compare different types of opioid tapering plans and will report on their effectiveness in producing sustained taper or discontinuation of long-term opioid therapy for chronic non-cancer pain while maintaining adequate pain control. The study population is KPWA patients receiving long-term opioid therapy from 2010 to 2017.

Conditions Studied

Interventions

  • OTHER Taper Plan

Study Locations (1)

Washington

  • Kaiser Permanente Washington Health Research Institute - Seattle

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2018-01-01
Est. Completion 2019-03-31

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT03748862

The ClinicalTrials.gov registry entry for NCT03748862 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opiate Replacement Therapy appearing as the primary indexed condition, and to 1 intervention - of which Taper Plan is the first listed.

NCT03748862 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT03748862 about?

NCT03748862 is a clinical study titled "The Effect of Primary Care Opioid Taper Plans on Sustained Opioid Taper". The objective of this study is to examine the effects of opioid taper plans as documented in the electronic medical record for Kaiser Permanente Washington (KPWA) patients. The study will compare different types of opioid tapering plans and will report on their effectiveness in producing sustained t...

What is the current status of trial NCT03748862?

This trial is currently completed. The enrollment target is 2,500 participants. The study started on 2018-01-01. Estimated completion is 2019-03-31.

What conditions does trial NCT03748862 study?

This clinical trial studies the following conditions: Opiate Replacement Therapy.

What interventions are being tested in trial NCT03748862?

The interventions under investigation include: Taper Plan (OTHER).

Who is sponsoring clinical trial NCT03748862?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03748862 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.